Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
Clinical trial NCT02471820 · COMPLETED
Trial details
- NCT number
- NCT02471820
- Sponsor
- Meletios A. Dimopoulos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-07-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.